ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
SHL Telemedicine Ltd

SHL Telemedicine Ltd (SHLT)

3.70
0.00
(0.00%)
終了 9月22日 5:00AM
3.46
0.00
(0.00%)
取引時間後: 7:00AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.70
買値
1.41
売値
5.61
出来高
86
3.67 日の範囲 3.67
0.00 52 週間の範囲 0.00
時価総額
前日終値
3.70
始値
3.67
時刻
1
@
3.46
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
16,392,754
配当利回り
-
PER
-39.85
1 株当たり利益 (EPS)
-0.43
歳入
57.08M
純利益
-7.06M

SHL Telemedicine Ltd について

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance comp... SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to the patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer's solutions include cardiac monitoring services. The company geographical segments Israel, Europe and the rest of the world. 詳細を表示

セクター
Health & Allied Services,nec
業界
Health & Allied Services,nec
ウェブサイト
本社
Tel Aviv, Center, Isr
設立
-
SHL Telemedicine Ltd is listed in the Health & Allied Services sector of the ナスダック市場 with ticker SHLT. The last closing price for SHL Telemedicine was US$3.70. Over the last year, SHL Telemedicine shares have traded in a share price range of US$ 0.00 to US$ 0.00.

SHL Telemedicine currently has 16,392,754 shares in issue. The market capitalisation of SHL Telemedicine is US$60.65 million. SHL Telemedicine has a price to earnings ratio (PE ratio) of -39.85.

SHLT 最新ニュース

SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine

David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the largest insurance groups in Israel SHL Telemedicine...

SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity

SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has clarified today that it is in...

SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test

Users in Israel will be able for the first time in the world to perform an at-home Biomarker blood test guided by SHL’s medical team, following ECG tests using The SmartHeart® for Rapid Heart...

SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch

A revolutionary at-home 12-lead ECG service with 24/7 cardiologist review and telehealth service now fully available in the US. SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the...

SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results...

Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care

Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits, underscoring SHL and SmartHeart®’s pivotal role in remote cardiac care SHL...

SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment

SHL’s SmartHeart portable 12-lead ECG technology successfully participated in the U.S. Army’s Project Convergence – Capstone 4 experiment (PC-C4), demonstrating exceptional reliability...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BNZIBanzai International Inc
US$ 5.645
(96.01%)
61.39M
ZJYLJin Medical International Ltd
US$ 3.975
(50.00%)
1.24M
ANEBAnebulo Pharmaceuticals Inc
US$ 2.9001
(39.43%)
78.85k
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
AENTAlliance Entertainment Holding Corporation
US$ 2.74
(34.31%)
4.23M
GSIWGarden Stage Ltd
US$ 1.34
(-82.89%)
26.44M
CRBPCorbus Pharmaceuticals Holdings Inc
US$ 19.51
(-62.26%)
12.29M
LGCBLinkage Global Inc
US$ 0.4183
(-57.70%)
2.16M
BFIBurgerFi International Inc
US$ 0.0855
(-42.27%)
15.05M
SKYESkye Bioscience Inc
US$ 3.17
(-42.26%)
5.14M
XPONExpion360 Inc
US$ 0.081
(39.18%)
1.46B
NVDANVIDIA Corporation
US$ 116.00
(-1.59%)
378.16M
AAPLApple Inc
US$ 228.20
(-0.29%)
320.24M
INTCIntel Corporation
US$ 21.84
(3.31%)
261.68M
VERBVerb Technology Company Inc
US$ 0.0742
(33.45%)
178.65M

最近閲覧した銘柄

Delayed Upgrade Clock